Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-01-01 @ 3:54 PM
Study NCT ID:
NCT01983735
Status:
UNKNOWN
Last Update Posted:
2013-11-14
First Post:
2013-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
Sponsor:
Chong Kun Dang Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-08
Completion Date Type:
ESTIMATED
First Submit Date:
2013-11-07
First Submit QC Date:
None
Study First Post Date:
2013-11-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-07
Last Update Post Date:
2013-11-14
Last Update Post Date Type:
ESTIMATED